Acute Anterior Uveitis: Psychic Burden and Pain

Anterior Uveitis Clinical Trial

Official title:

Acute Anterior Uveitis: Psychic Burden and Pain

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01156285
• Other study ID #: MAC110
• Status: Recruiting
• Phase: N/A
• First received: July 1, 2010
• Last updated: November 27, 2011
• Start date: May 2010
• Est. completion date: June 2012

Study information

• Verified date: November 2011
• Source: Hospital Hietzing
• Contact: Saskia M Maca, MD
• Phone: +43-1-80110
• Email: Saskia.Maca[@]wienkav.at
• Is FDA regulated: No
• Health authority: Austria: Ethics committee of the city of Vienna
• Study type: Observational

Clinical Trial Summary

Acute anterior uveitis (AU) is a common reason for attendance at ophthalmic outpatient clinics. The painfulness and the fear of a transient or even persistent loss of vision may markedly reduce the individual's subjective well-being and pose a psychological burden.

This study will test the hypothesis that during an attack of AU the patient experiences a marked reduction in psychological and physical well-being.

Prospective, hospital-based epidemiologic study using a patient questionnaire with standardized psychological tests and a pain scale.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 35
• Est. completion date: June 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Acute attack of anterior uveitis

Exclusion Criteria:

• Other forms of uveitis

• Chronic anterior uveitis

• Therapy started

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Anterior Uveitis
• Iridocyclitis
• Iritis
• Uveitis
• Uveitis, Anterior

Intervention

Other:
• Filling in a patient questionnaire
Filling in a patient questionnaire

Locations

Country	Name	City	State
Austria	Department of Ophthalmology, Medical University Graz	Graz	Styria
Austria	Department of Ophthalmology, Hietzing Hospital	Vienna

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Hietzing	Medical University of Graz

Country where clinical trial is conducted

Austria,